World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
128
Citations
93430
World Ranking
2645
National Ranking
50

Ulf de Faire publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Ulf de Faire sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 476 publications — 54th percentile

54% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Ulf de Faire D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Ulf de Faire sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 128 D-Index — 87th percentile

87% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Ulf de Faire is affiliated with the Karolinska Institute in Sweden and has contributed extensively to the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Their research primarily spans cardiology and cardiovascular medicine, immunology, epidemiology, molecular biology, and genetics.

Their work addresses several key topics including:

  • Atherosclerosis and Cardiovascular Diseases
  • Adipokines, Inflammation, and Metabolic Diseases
  • Genetic Associations and Epidemiology
  • Cardiovascular Disease and Adiposity
  • S100 Proteins and Annexins
  • Cerebrovascular and Carotid Artery Diseases
  • Air Quality and Health Impacts

Ulf de Faire has published research in various venues, with frequent contributions to:

  • Circulation
  • PLoS Medicine
  • European Journal of Preventive Cardiology
  • BMC Neurology
  • European Heart Journal

Significant recent papers include:

  • "Prevalence of Subclinical Coronary Artery Atherosclerosis in the General Population," 2021, Circulation
  • "Long-term exposure to low-level ambient air pollution and incidence of stroke and coronary heart disease: a pooled analysis of six European cohorts within the ELAPSE project," 2021, The Lancet Planetary Health
  • "Biomarkers of dairy fat intake, incident cardiovascular disease, and all-cause mortality: A cohort study, systematic review, and meta-analysis," 2021, PLoS Medicine
  • "PCSK6 Is a Key Protease in the Control of Smooth Muscle Cell Function in Vascular Remodeling," 2020, Circulation Research
  • "Long-term risk of a major cardiovascular event by apoB, apoA-1, and the apoB/apoA-1 ratio-Experience from the Swedish AMORIS cohort: A cohort study," 2021, PLoS Medicine

Collaborations are an important aspect of their research, with frequent co-authors including:

  • Karin Leander
  • Bruna Gigante
  • Federica Laguzzi
  • Damiano Baldassarre
  • Fabrizio Veglia

Best Publications

  • Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.

    Björn Dahlöf;Richard B Devereux;Sverre E Kjeldsen;Stevo Julius

  • Biological, clinical and population relevance of 95 loci for blood lipids

    Tanya M. Teslovich;Kiran Musunuru;Albert V. Smith;Andrew C. Edmondson

  • Discovery and refinement of loci associated with lipid levels

    Cristen J. Willer;Ellen M. Schmidt;Sebanti Sengupta;Gina M. Peloso;Gina M. Peloso;Gina M. Peloso

  • Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

    Lennart Hansson;Lars H Lindholm;Leo Niskanen;Jan Lanke

  • Plasma HDL cholesterol and risk of myocardial infarction: A mendelian randomisation study

    Benjamin F. Voight;Benjamin F. Voight;Benjamin F. Voight;Gina M. Peloso;Gina M. Peloso;Marju Orho-Melander;Ruth Frikke-Schmidt

  • Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.

    Lars H Lindholm;Hans Ibsen;Björn Dahlöf;Richard B Devereux

  • Defining the role of common variation in the genomic and biological architecture of adult human height

    Andrew R. Wood;Tonu Esko;Jian Yang;Sailaja Vedantam

  • Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease

    Heribert Schunkert;Inke R. König;Sekar Kathiresan;Muredach P. Reilly

  • Air pollution and lung cancer incidence in 17 European cohorts : Prospective analyses from the European Study of Cohorts for Air Pollution Effects (ESCAPE)

    Ole Raaschou-Nielsen;Zorana Jovanovic Andersen;Rob Beelen;Evangelia Samoli

  • Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes

    Andrew P Morris;Benjamin F Voight;Benjamin F Voight;Tanya M Teslovich;Teresa Ferreira

  • Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study.

    Lennart Hansson;Lars H Lindholm;Tord Ekbom;Björn Dahlöf

  • Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction.

    Anders Hamsten;Göran Walldius;Alfred Szamosi;Margareta Blombäck

  • Genetic Variants Associated with Lp(a) Lipoprotein Level and Coronary Disease

    R Clarke;J F Peden;J C Hopewell;T Kyriakou

  • Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction

    A Hamsten;B Wiman;U de Faire;M Blombäck

  • Large-scale association analysis identifies new risk loci for coronary artery disease

    Panos Deloukas;Stavroula Kanoni;Christina Willenborg;Martin Farrall

  • Genetic studies of body mass index yield new insights for obesity biology

    Adam E. Locke;Bratati Kahali;Sonja I. Berndt;Anne E. Justice

  • Genetic Susceptibility to Death from Coronary Heart Disease in a Study of Twins

    M E Marenberg;N Risch;L F Berkman;B Floderus

  • Effects of long-term exposure to air pollution on natural-cause mortality : An analysis of 22 European cohorts within the multicentre ESCAPE project

    Rob Beelen;Ole Raaschou-Nielsen;Massimo Stafoggia;Zorana Jovanovic Andersen

  • Randomised trial of effects of calcium antagonists compared with diuretics and β-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study

    Lennart Hansson;Thomas Hedner;Per Lund-Johansen;Sverre Erik Kjeldsen

  • The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis.

    D I Swerdlow;M V Holmes;K B Kuchenbaecker

Frequent Co-Authors

Anders Hamsten
Anders Hamsten Karolinska Institute
Nancy L. Pedersen
Nancy L. Pedersen Karolinska Institute
Rona J. Strawbridge
Rona J. Strawbridge University of Glasgow
Elena Tremoli
Elena Tremoli University of Milan
Rainer Rauramaa
Rainer Rauramaa University of Eastern Finland
Erik Ingelsson
Erik Ingelsson Stanford University
Steve E. Humphries
Steve E. Humphries University College London
Kari Stefansson
Kari Stefansson deCODE Genetics (Iceland)
Nicholas J. Wareham
Nicholas J. Wareham University of Cambridge
Philippe Froguel
Philippe Froguel Imperial College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine isn’t limited to traditional medical school. There are many related online degrees and alternative career pathways in healthcare. These options can open doors to essential roles in the industry and offer more flexible, affordable routes to entering the field.

For those interested in the intersection of healthcare and technology, there are health information technology programs online that prepare you to manage and secure health data, an increasingly critical area in healthcare management.

Students looking for quick entry into high-demand roles can consider medical billing and coding online courses. These courses train you to support healthcare providers by managing billing processes, medical records, and insurance claims.

If you’re focused on patient care, but medical school is out of reach, nursing may be the right path. The cheapest online nursing program options provide affordable ways to earn your RN or BSN. For those who are already nurses and wish to advance, cheapest fnp programs online enable you to become a Family Nurse Practitioner without relocating or sacrificing your current job.

These online healthcare programs offer strong career prospects, flexibility, and accessible paths into growing healthcare fields.

Best Scientists Citing Ulf de Faire

Trending Scientists

Recently Published Articles